Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-27,192
Closed -$420K 744
2023
Q3
$420K Sell
27,192
-1,700
-6% -$28.5K 0.01% 450
2023
Q2
$548K Hold
28,892
0.02% 381
2023
Q1
$440K Hold
28,892
0.02% 417
2022
Q4
$368K Hold
28,892
0.01% 466
2022
Q3
$167K Sell
28,892
-800
-3% -$3.52K 0.01% 617
2022
Q2
$96K Buy
+29,692
New +$89.6K ﹤0.01% 653

Other funds holding ETNB

Bailard's ETNB Position: Q4 2023 in Review

Bailard sold out of 89bio (ETNB) in Q4 2023, closing a stake of 27,192 shares — an estimated $420K sold.

Bailard first reported a position in ETNB in Q2 2022 and held it in 6 quarters. The position peaked at $548K in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Bailard reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Bailard sold 27,192 89bio shares in Q4 2023, an estimated $420K.
  • Bailard first reported a position in 89bio in Q2 2022 and held it in 6 quarters.
  • Bailard's 89bio position peaked at $548K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.